Reduced Serotonin Receptor Subtypes in a Limbic and a Neocortical Region in Autism
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Autism is a behaviorally defined, neurological disorder with symptom onset before the age of 3. Abnormalities in social‐emotional behaviors are a core deficit in autism, and are characterized by impaired reciprocal–social interaction, lack of facial expressions, and the inability to recognize familiar faces. The posterior cingulate cortex (PCC) and fusiform gyrus (FG) are two regions within an extensive limbic‐cortical network that contribute to social‐emotional behaviors. Evidence indicates that changes in brains of individuals with autism begin prenatally. Serotonin (5‐HT) is one of the earliest expressed neurotransmitters, and plays an important role in synaptogenesis, neurite outgrowth, and neuronal migration. Abnormalities in 5‐HT systems have been implicated in several psychiatric disorders, including autism, as evidenced by immunology, imaging, genetics, pharmacotherapy, and neuropathology. Although information is known regarding peripheral 5‐HT in autism, there is emerging evidence that 5‐HT systems in the central nervous system, including various 5‐HT receptor subtypes and transporters, are affected in autism. The present study demonstrated significant reductions in 5‐HT 1A receptor‐binding density in superficial and deep layers of the PCC and FG, and in the density of 5‐HT 2A receptors in superficial layers of the PCC and FG. A significant reduction in the density of serotonin transporters (5‐HTT) was also found in the deep layers of the FG, but normal levels were demonstrated in both layers of the PCC and superficial layers of the FG. This study provides potential substrates for decreased 5‐HT modulation/innervation in the autism brain, and implicate two 5‐HT receptor subtypes as potential neuromarkers for novel or existing pharmacotherapies. Autism Res 2013, 6: 571–583. © 2013 International Society for Autism Research, Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gaze fixation and the neural circuitry of face processing in autism
Dalton, K. M., Nacewicz, B. M., Johnstone, T., Schaefer, H. S., Gernsbacher, M. A., Goldsmith, H. H., Alexander, A. L., & Davidson, R. J. (2005) · Nature Neuroscience · doi:10.1038/nn1421 · Cited by 1,543 · cited 1×
“Several groups have looked at the activation of the FG in autism, with results suggesting either no change in activation of the FG compared with controls or decreased activation of this area in autism [e.g. Dalton et al., 2005; Hadjikhani et al., 2004].”
ResultHistoanatomic observations of the brain in early infantile autism
Bauman, M., & Kemper, T. L. (1985) · Neurology · doi:10.1212/wnl.35.6.866 · Cited by 964
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children
Schain, R. J., & Freedman, D. X. (1961) · The Journal of Pediatrics · doi:10.1016/s0022-3476(61)80261-8 · Cited by 579 · cited 2×
“…et al., 1987; Cook & Leventhal, 1996; Cook et al., 1993; Lam, Aman, & Arnold, 2006; LeBoyer et al., 1999; Leventhal et al., 1990; McBride et al., 1998; Piven et al., 1991; Schain & Freedman, 1961; Singh et al., 1997], suggesting dysfunction of the 5-HT system in autism [Hranilovic et al., 2007].”
BackgroundKing, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 2×
“Genetic studies have linked serotonin transporter gene (SLC6A4) polymorphisms, and genes regulating 5-HT neurotransmission to autism vulnerability and symptom severity [Brune et al., 2006; Sutcliffe et al., 2005; Wassink et al., 2007].”
BackgroundBrain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism
Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., Tsuchiya, K. J., Sugihara, G., Iwata, Y., Suzuki, K., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.137 · Cited by 352
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318 · cited 1×
“Pharmacological studies have provided evidence for central serotonin dysfunction in autism, including the serotonin uptake sites or transporters [5-HTT; Lam et al., 2006].”
BackgroundWhole blood serotonin in autistic and normal subjects
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1987.tb00677.x · Cited by 313
López-Figueroa, A. L., Norton, C. S., López-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., López, J. F., & Watson, S. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.017 · Cited by 296 · cited 1×
“Alterations in 5-HT1A receptor binding in humans are linked to fewer psychiatric disorders than 5-HT2A receptors, but are commonly observed in studies of major depression and epilepsy [López-Figueroa et al., 2004; Merlet et al., 2004; Meschaks, Lindstrom, Halldin, Farde, & Savic, 2005].”
BackgroundPsychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Neurons in the fusiform gyrus are fewer and smaller in autism
van Kooten, I. A. J., Palmen, S. J. M. C., von Cappeln, P., Steinbusch, H. W. M., Korr, H., Heinsen, H., Hof, P. R., van Engeland, H., & Schmitz, C. (2008) · Brain · doi:10.1093/brain/awn033 · Cited by 263
Risperidone in Children With Autism: Randomized, Placebo-Controlled, Double-Blind Study
Nagaraj, R., Singhi, P., & Malhi, P. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210060801 · Cited by 214
Decreased GABA B receptors in the cingulate cortex and fusiform gyrus in Autism
Oblak, A. L., Gibbs, T. T., & Blatt, G. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06858.x · Cited by 203
Self-citationMedication use among children with autism spectrum disorders
Oswald, D. P., & Sonenklar, N. A. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.17303 · Cited by 195
Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.-C., & Launay, J.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00532-5 · Cited by 194 · cited 1×
“…autism and/or their relatives [Abramson et al., 1989; Anderson et al., 1987; Cook & Leventhal, 1996; Cook et al., 1993; Lam, Aman, & Arnold, 2006; LeBoyer et al., 1999; Leventhal et al., 1990; McBride et al., 1998; Piven et al., 1991; Schain & Freedman, 1961; Singh et al., 1997], suggesting…”
Uddin, L. Q., Menon, V., Young, C. B., Ryali, S., Chen, T., Khouzam, A., Minshew, N. J., & Hardan, A. Y. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.014 · Cited by 187
Serotonin and dopamine transporter binding in children with autism determined by SPECT
Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M. M., & Kuikka, J. T. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03027.x · Cited by 169
MCBRIDE, P. A., ANDERSON, G. M., HERTZIG, M. E., SNOW, M. E., THOMPSON, S. M., KHAIT, V. D., SHAPIRO, T., & COHEN, D. J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199807000-00017 · Cited by 141 · cited 2×
“hyperserotonemia) have been found in approximately one third of individuals with autism and/or their relatives [Abramson et al., 1989; Anderson et al., 1987; Cook & Leventhal, 1996; Cook et al., 1993; Lam, Aman, & Arnold, 2006; LeBoyer et al., 1999; Leventhal et al., 1990; McBride et al., 1998; Piven et al., 1991; Sch…”
BackgroundElevated blood serotonin in autistic probands and their first-degree relatives
Abramson, R. K., Wright, H. H., Carpenter, R., Brennan, W., Lumpuy, O., Cole, E., & Young, S. R. (1989) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02212938 · Cited by 123 · cited 2×
“hyperserotonemia) have been found in approximately one third of individuals with autism and/or their relatives [Abramson et al., 1989; Anderson et al., 1987; Cook & Leventhal, 1996; Cook et al., 1993; Lam, Aman, & Arnold, 2006; LeBoyer et al., 1999; Leventhal et al., 1990; McBride et al., 1998; Piven et al., 1991; Sch…”
BackgroundAzmitia, E. C., Singh, J. S., & Whitaker-Azmitia, P. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.002 · Cited by 107
Relationships of whole blood serotonin and plasma norepinephrine within families
Leventhal, B. L., Cook, E. H., Morford, M., Ravitz, A., & Freedman, D. X. (1990) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02216055 · Cited by 102 · cited 2×
“…relatives [Abramson et al., 1989; Anderson et al., 1987; Cook & Leventhal, 1996; Cook et al., 1993; Lam, Aman, & Arnold, 2006; LeBoyer et al., 1999; Leventhal et al., 1990; McBride et al., 1998; Piven et al., 1991; Schain & Freedman, 1961; Singh et al., 1997], suggesting dysfunction of the 5-HT…”
BackgroundSingh, V. K., Singh, E. A., & Warren, R. P. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00522-7 · Cited by 99
Blankenship, K., Erickson, C. A., Stigler, K. A., Posey, D. J., & McDougle, C. J. (2010) · Pediatric Health · doi:10.2217/phe.10.45 · Cited by 75
Research works printed but not linked: 45
- 10.1007/BF01048241 · DOI
- 10.1093/brain/121.5.889 · DOI · Paper page
- Baio J., 2012, Prevalence of autism spectrum disorders — Autism and developmental disabilities monitoring network, 14 sites, United States, 2008, National Center on Birth Defects and Developmental Disabilities, CDC, Morbidity and Mortality Weekly Report (MMWR), Surveillance Summaries, 61, 1
- Brodmann K., 1909, Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues
- Brune C.W., 2006, 5‐HTTLPR genotype‐specific phenotype in children and adolescents with autism, The American Journal of Psychiatry, 163, 2148, 10.1176/ajp.2006.163.12.2148 · DOI · Paper page
- 10.1002/ana.20196 · DOI · Paper page
- 10.1177/1073858406290375 · DOI · Paper page
- 10.1177/1073858403253552 · DOI · Paper page
- 10.1046/j.1528-1157.2002.34101.x · doi:10.1046/j.1528-1157.2002.34101.x
- 10.1002/14651858.CD009043.pub2 · DOI
- 10.1097/00008480-199608000-00008 · DOI · Paper page
- 10.1016/0024-3205(93)90685-V · DOI · Paper page
- 10.1089/104454602760386932 · DOI · Paper page
- 10.1001/archgenpsychiatry.2012.513 · DOI · Paper page
- 10.1111/j.1469-8749.1998.tb15414.x · DOI · Paper page
- 10.1016/0006-8993(85)91613-0 · DOI · Paper page
- 10.1111/j.1469-7610.1990.tb00834.x · DOI · Paper page
- 10.1007/s10803-008-0604-4 · DOI
- 10.1016/j.neuroimage.2004.03.025 · DOI · Paper page
- 10.1038/sj.npp.1300627 · DOI · Paper page
- Hoshino Y., 1987, Clinical features of autistic children with setback course in their infancy, The Japanese Journal of Psychiatry and Neurology, 41, 237
- 10.1007/s10803-006-0324-6 · DOI
- 10.1523/JNEUROSCI.17-11-04302.1997 · DOI · Paper page
- 10.1176/appi.ajp.162.6.1142 · DOI · Paper page
- 10.1016/j.neuroimage.2004.02.014 · DOI
- 10.1001/archneur.62.6.946 · doi:10.1001/archneur.62.6.946
- 10.1176/ajp.2006.163.5.934 · DOI · Paper page
- 10.1097/00004703-200304000-00005 · DOI · Paper page
- 10.1523/JNEUROSCI.2792-11.2011 · DOI · Paper page
- 10.1002/aur.88 · DOI · Paper page
- 10.1016/j.brainres.2010.09.021 · DOI · Paper page
- 10.1002/aur.188 · DOI · Paper page
- 10.1007/s10803-011-1240-y · DOI
- 10.1177/002215549804601006 · DOI
- 10.1089/cap.2006.16.379 · DOI · Paper page
- 10.1007/BF02206997 · DOI
- 10.1089/cap.2006.16.181 · DOI · Paper page
- 10.1542/peds.2003-0264-F · DOI · Paper page
- 10.1007/s00401-009-0568-2 · DOI · Paper page
- 10.1111/j.1601-183X.2008.00390.x · DOI · Paper page
- 10.1016/j.ejphar.2005.02.051 · DOI
- 10.1001/archpsyc.64.6.709 · DOI · Paper page
- 10.1016/j.neuroimage.2010.04.262 · DOI · Paper page
- 10.1016/j.brainres.2009.11.057 · DOI · Paper page
- West L., 2006, Risperidone use in the treatment of behavioral symptoms in children with autism, Pediatric Nursing, 32, 545
Cited by
Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., Jones, R. M., Pickles, A., State, M. W., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0138-4 · Cited by 1,859
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“A postmortem study found decreases in both 5-HT2A and 5-HT1A binding in ASD (Oblak et al., 2013).”
BackgroundThe Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Fetit, R., Hillary, R. F., Price, D. J., & Lawrie, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.014 · Cited by 148
Prenatal paracetamol exposure and child neurodevelopment: A review
Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C.-G., & Swan, S. H. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.01.003 · Cited by 127
“Disturbances to the neurological function of these same systems have been implicated in ASD and ADHD etiology (Quaak et al., 2013; Lee et al., 2017; Oblak et al., 2013; Pezze et al., 2014; Ming et al., 2012; Harada et al., 2011; Naaijen et al., 2015).”
Metadata
- Authors
- Oblak, A., Gibbs, T. T., & Blatt, G. J.
- Venue
- Autism Research
- Publisher
- Wiley
- Published
- 2013-07-24
- Volume
- 6
- Issue
- 6
- Pages
- 571-583
- ISSN
- 1939-3792 (ISSN-L)
- 1939-3806
- OpenAlex
- W1484440311
- Cited by
- 97
- References
- 23
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Studies to Advance Autism Research and Treatment (STAART) grant from the National Institutes of Health (U54 MH66398)
- The Nancy Lurie Marks Foundation
- The Hussman Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.